Type 2 diabetes mellitus (T2DM), comprising ~ 90% of diabetes cases, is driven by insulin resistance (IR) and -cell dysfunction, with oxidative stress and chronic inflammation as key pathogenic factors (Garg et al
One of the most impactful effects is sustainable weight loss, which can help restore ovulation and reduce many PCOS-related symptoms
For the broader peptide and metabolic-disease audience: orforglipron's April 1, 2026 FDA approval as Foundayo was a market event
As availability expands and public interest surges, misuse, off-label use, and dosing errors are likely to rise as well
Advertising and Consumer Perception The extensive advertising of these medications has led to increased patient requests, sometimes for uses that are not approved
Parrado C, Mercado-Saenz S, Perez-Davo A, Gilaberte Y, Gonzalez S, Juarranz A